Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
出版年份 2021 全文链接
标题
Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
作者
关键词
-
出版物
Frontiers in Genetics
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-07-23
DOI
10.3389/fgene.2021.699455
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
- (2021) Vasiliki Lagou et al. Nature Communications
- Use of Multivariable Mendelian Randomization to Address Biases Due to Competing Risk Before Recruitment
- (2021) C. M. Schooling et al. Frontiers in Genetics
- Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations
- (2021) Fernando Pires Hartwig et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study
- (2021) Shiu Lun Au Yeung et al. THORAX
- Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
- (2020) Sonia Shah et al. Nature Communications
- Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study
- (2020) Shan Luo et al. DIABETOLOGIA
- Higher Fibroblast Growth Factor 23 Levels Are Causally Associated With Lower Bone Mineral Density of Heel and Femoral Neck: Evidence From Two-Sample Mendelian Randomization Analysis
- (2020) Yue Wang et al. Frontiers in Public Health
- A phenome-wide association study of ABO blood groups
- (2020) Shun Li et al. BMC Medicine
- Association of Fibroblast Growth Factor 23 With Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study
- (2020) Kai Zheng et al. Frontiers in Genetics
- Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization study
- (2020) Maki Yokomoto-Umakoshi et al. BONE
- Meta-Analysis and Mendelian randomization: A review
- (2019) Jack Bowden et al. Research Synthesis Methods
- FGF23: Clinical usefulness and analytical evolution
- (2019) Charlotte Fauconnier et al. CLINICAL BIOCHEMISTRY
- Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors
- (2019) Ram Jagannathan et al. Current Diabetes Reports
- The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
- (2019) Shiu Lun Au Yeung et al. DIABETOLOGIA
- A catalog of genetic loci associated with kidney function from analyses of a million individuals
- (2019) Matthias Wuttke et al. NATURE GENETICS
- Genetic Prediction of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels in Relation to Development of Type 2 Diabetes: A Mendelian Randomization Study
- (2019) Shuai Yuan et al. DIABETES CARE
- Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis
- (2019) Klemen Kodrič et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A meta-analysis of genome-wide association studies identifies multiple longevity genes
- (2019) Joris Deelen et al. Nature Communications
- Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria
- (2019) Alexander Teumer et al. Nature Communications
- Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
- (2018) Amarnath Marthi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
- (2018) James Yarmolinsky et al. JNCI-Journal of the National Cancer Institute
- AMP-activated kinase is a regulator of fibroblast growth factor 23 production
- (2018) Philipp Glosse et al. KIDNEY INTERNATIONAL
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases
- (2018) Masahiro Kanai et al. NATURE GENETICS
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
- (2018) Anubha Mahajan et al. NATURE GENETICS
- Multi-ethnic genome-wide association study for atrial fibrillation
- (2018) Carolina Roselli et al. NATURE GENETICS
- Insulin suppresses the production of fibroblast growth factor 23 (FGF23)
- (2018) Ludmilla Bär et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- The MR-Base platform supports systematic causal inference across the human phenome
- (2018) Gibran Hemani et al. eLife
- Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
- (2018) James Yarmolinsky et al. JNCI-Journal of the National Cancer Institute
- Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry
- (2018) Loic Yengo et al. HUMAN MOLECULAR GENETICS
- Genetic Variants Associated with Circulating Fibroblast Growth Factor 23
- (2018) Cassianne Robinson-Cohen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis
- (2017) Eleanor Wheeler et al. PLOS MEDICINE
- A Mendelian randomization study of the effect of calcium on coronary artery disease, myocardial infarction and their risk factors
- (2017) Lin Xu et al. Scientific Reports
- 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function
- (2017) Mathias Gorski et al. Scientific Reports
- Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
- (2016) Yuichi Takashi et al. ENDOCRINE RESEARCH
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
- (2016) Jack Bowden et al. GENETIC EPIDEMIOLOGY
- Bias due to participant overlap in two-sample Mendelian randomization
- (2016) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- Commentary: Two-sample Mendelian randomization: opportunities and challenges
- (2016) Debbie A Lawlor INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Serum fibroblast growth factor-23 and incident hypertension
- (2016) Amber L. Fyfe-Johnson et al. JOURNAL OF HYPERTENSION
- FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
- (2016) Helen V Alderson et al. NEPHROLOGY
- The effect of hematocrit and hemoglobin on the risk of ischemic heart disease: A Mendelian randomization study
- (2016) Y. Zhong et al. PREVENTIVE MEDICINE
- FGF-23 and cardiovascular disease
- (2016) Jasveen Batra et al. Current Opinion in Endocrinology Diabetes and Obesity
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
- (2015) J. Bowden et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
- (2015) Majid Nikpay et al. NATURE GENETICS
- Contributions of risk factors and medical care to cardiovascular mortality trends
- (2015) Majid Ezzati et al. Nature Reviews Cardiology
- A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
- (2015) Omar S. Ahmad et al. Nature Communications
- Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
- (2014) Jehu S. Mathew et al. CIRCULATION
- Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
- (2014) Romina di Giuseppe et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome
- (2014) S. Burgess INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Power and sample size calculations for Mendelian randomization studies using one genetic instrument
- (2013) G. Freeman et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The role of estrogen and androgen receptors in bone health and disease
- (2013) Stavros C. Manolagas et al. Nature Reviews Endocrinology
- Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort
- (2013) Adeera Levin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the "Trade-off" Hypothesis
- (2010) O. M. Gutierrez Clinical Journal of the American Society of Nephrology
- The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
- (2009) M. Shawkat Razzaque Nature Reviews Endocrinology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now